Episode 05 · 44 min

Why MDelite tests every device on its own patients first

With James Schoemehl, MDelite

MDelite proved itself in the conservative vision market before entering aesthetics. CEO James Schoemehl tells Tim why the sale is where support begins, and why every device gets tested in his own med spa first.

Embedded YouTube is blocked inside this preview. On the live site the episode plays right here.

James Schoemehl spent twenty-seven years selling aesthetic devices before he and his wife bought a med spa in 2017. When COVID closed its doors, he used the downtime to call old research and development contacts and start sourcing devices of their own. That became MDelite, a company now established in the vision market and preparing its move into aesthetics in 2027.

In this episode of the MedTech Founders Club, James talks with Tim Dingersen about breaking through in a crowded market, why every MDelite device has to earn its place in his own med spas, and what it means to build the company you would want to buy from.

From device rep to med spa owner to founder

James came up in aesthetics when med spas weren't a thing yet, selling to plastic surgeons and dermatologists in private practice. Over the years he gravitated toward startups, where he could use his entrepreneurial streak without giving up a salary.

“That's where I could flex this entrepreneurial spirit that was always kind of burning inside of me.”

The med spa changed his view of the industry. He and his wife bought it so one of them could get off the road, and it grew every year. Then COVID forced it to close. With time on his hands and no budget for multimillion-dollar equipment purchases, James started asking contacts he knew in research and development how they could source their own devices. They tested those devices in the spa, and the idea for MDelite took shape.

Why MDelite started in vision, not aesthetics

James's background is all aesthetics, so the first market was a surprise. His partner Blair, an industry veteran, brought the vision opportunity to the table. An IPL from a large aesthetics company was already being used for dry eye, which gave MDelite an entry point.

“There were so many similarities in the vision space to what I remember the aesthetics space being twenty years ago.”

Vision buyers turned out to be very different from today's aesthetics buyers. They were conservative, did their research, and expected support long after the sale. James says it reminded him of aesthetics twenty years ago, when a company had to prove its device worked and keep earning the business. A key opinion leader gave him the insight that tied it together: eye health is indicative of overall health, and the patients who care about their vision are often the same patients interested in aesthetic treatments.

Customer support starts after the sale

For James, standing out comes down to people. MDelite hires selectively and trains its reps to understand the whole practice, from how a new device fits alongside injectables to how the front desk answers the phone. By the six-month mark, the team has checked in and held up its end of the bargain.

“For us, the responsibility to our client begins when they buy a device from us. It doesn't end.”

He believes buyers want to know three things: does the device clinically do what you say, how specifically will you support me after the sale, and will I get a positive return on the investment. Owning a med spa showed him how narrowly reps, himself included, had focused on the sale alone. Done right, the result is word of mouth, with new practices calling because a peer raved about MDelite.

Every device is tested in their own med spas first

Before any MDelite device is commercially available, it goes through James's own spas. The team models it financially, uses it on clients, friends and family, and asks staff for honest feedback, not just on results but on the patient experience. Plenty of devices never make it.

“I don't need every customer. We're going to get the right customers that view themselves as partners.”

That testing changed the eleo IPL platform. Contact cooling had become an industry standard, but feedback from vision clinicians showed that treating small areas of vascularity worked better without it. MDelite took the risk and redesigned the handpiece. James expects some pushback as the company moves into aesthetics, and he is comfortable with it.

Self-funded means you can say no

MDelite is privately owned, and James calls that the best position of his career. Outside inquiries are flattering, but answering to investors would mean running the business someone else's way. Being self-funded lets the team take its time, walk away from the wrong opportunities and take thoughtful risks on the right ones.

Investing in a brand with substance

James has watched brands launch with nothing behind them, and he says the truth eventually comes out. MDelite's approach is to do right by its customers first and keep reinvesting as their expectations grow, in training, resources and how the company presents itself. A strong brand also makes the sales team's job easier. He wants every rep to walk into an office with confidence and several levers to pull.

“I want our brand to tell the story of who MDelite is, and who the people at MDelite are.”

What's next: aesthetics in 2027

MDelite is taking a deliberate approach to aesthetics. Matt Donaldson, a longtime friend of James's from the industry, will run the aesthetics side end to end, while James and the executive team stay focused on vision, including additional FDA applications. Four devices are in testing now, and James expects one or two launches in 2027, one in each market.

James's advice for medtech founders

Know your intentions. For MDelite, the goal was never to be the biggest company in aesthetics or vision. It was to become a trusted resource and to grow responsibly on a strong foundation, with high standards for its people, its products and every customer interaction. Borrowing a term from his time in vision, James says the daily approach should be myopic: get the blocking and tackling right, and the bigger picture takes care of itself.

“If we do all of those things right, revenue will follow and the brand will be well known, respected and trusted.”

Key takeaways

  • Test your device where you would use it. MDelite proves clinical, financial and patient experience results in its own med spas before launch.
  • A conservative market can be the best place to start. Vision buyers forced MDelite to earn trust, a foundation it now brings to aesthetics.
  • Support is part of the product. Buyers want proof it works, a clear support plan and a positive return.
  • Self-funding is hard, but it buys the freedom to say no.

More conversations.

All episodes →

For founders

Share your story
with us.

Every founder who comes on the show walks away with a podcast episode and a ten-page presentation deck built from their conversation. One hour of your time. Yours to keep, on us.

Apply to be a guest →